跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
NRA-ALENDRONATE
Authorized
STANDARD
NRA-ALENDRONATE
nora pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e050b0685e373701
Company
nora pharma inc
Type
Standard
Approval Details
Approval Id
e050b0685e373701
Drug Approval Canada Name
NRA-ALENDRONATE
Product Name
NRA-ALENDRONATE
Status
Marketed
Status Date
2022-08-09
Original Market Date
2022-08-09
Din
02523116
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:24.00
Atc Original
M05BA04 ALENDRONIC ACID
Atc Name
m 05 ba 04
Aig Number
0150323002
Company Name
nora pharma inc
Company Address
1565 Lionel-Boulet Blvd., Varennes, Quebec, Canada, J3X 1P7
Active Ingredients
ALENDRONIC ACID (ALENDRONATE SODIUM)
70 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e050b0685e373701
Type
Standard
Back to Health Canada Approvals
NRA-ALENDRONATE - Health Canada Drug Approval Details